Skip to content
Screener

Glaukos GKOS Q3 2026 earnings

Reported October 28, 2026 · After market close

Revenue$211.0MBeat by $43.0M
EPS$0.47Beat by $0.57
Revenue estimate$168.0M
EPS estimate-$0.10
“Our record third quarter results reflect successful global execution across our key global commercial and development priorities, leaving us well positioned to sustain our strong growth momentum driven by two transformational growth drivers in iDose TR and Epioxa. We continue to successfully advance our robust pipeline of novel, dropless platform technologies designed to meaningfully advance the standard of care and improve outcomes for patients suffering from chronic eye diseases.”
Thomas Burns

Next report

Date not yet announced

Financials

Q3 2026

Income statement

See full
Revenue$211.0M+58.0%
Gross profit$179.9M+71.8%
Operating income$828.0K+105%
Net income$2.0M+112%
EPS (diluted)$0.03+111%

Balance sheet

See full
Cash & equivalents$162.3M+65.2%
Total debt$105.1M-1.5%
Total equity$717.3M-6.8%
Total assets$979.5M-2.0%

Cash flow

See full
Operating cash flow$38.6M+482%
CapEx$2.1M+27.2%
Free cash flow$36.5M+411%

Valuation & ratios

Valuation

as of 10/30/26
See full
Market cap$14.35B+185%
Enterprise value$14.3B+183%
P/S20.8×+10.1×

Profitability

See full
Gross margin65%-11.9pp
Operating margin-25.5%+14.1pp
Net margin-24.6%+11.5pp

Returns & leverage

See full
Return on equity-22.8%+159pp
Debt / equity0.1×0.0×
Current ratio4.6×-0.6×

Segments

By product

See full
Glaucoma$152.0M+37.9%
Corneal Health$59.0M+154%

By geography

See full
Non Us$36.2M+12.8%

FAQ

When did Glaukos report Q3 2026 earnings?
Glaukos (GKOS) reported Q3 2026 earnings on October 28, 2026 after market close.
What were Glaukos's Q3 2026 revenue and EPS?
Glaukos reported revenue of $211.0M and eps of $0.47 for Q3 2026.
Did Glaukos beat estimates in Q3 2026?
Revenue beat the consensus estimate of $168.0M by $43.0M. EPS beat the consensus estimate of $-0.10 by $0.57.
How did Glaukos's Q3 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 58.0% from $133.5M a year earlier.
Where can I find Glaukos's Q3 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-436147) and the 10-Q periodic report (0001193125-26-436400) directly on SEC EDGAR. The filing index links above go to sec.gov.